Identification of the various stages of the seminal tubule epithelium that are important in spermatogenesis in humans and rodents requires considerable expertise for analysis of ultrastructural appearance under light microscopy. Few good stagespecific markers have been reported to facilitate the process. We recently described characterization of the expression of CD46 (membrane cofactor protein) in the rat using a novel monoclonal antibody. Expression of CD46 was restricted to spermatozoa and their immediate precursors in the testis. In the present study, we used a combination of morphological analyses, known acrosome markers, actin staining, direct nuclear staining, and staining for CD46 to delineate precisely the subcellular location of CD46. Staining of CD46 colocalized with known acrosome markers in late spermatids and mature spermatozoa and was confirmed by electron microscopy to be acrosome-restricted. Expression was first detected in step 7 spermatids, whereas known markers were not expressed until step 9. The CD46 staining pattern differed through spermatid development, and distinct patterns of staining could be identified that, when combined with 4-6-diamino-2-phenylindole-2HCl nuclear staining, enabled the accurate staging of the seminiferous tubule epithelium in different profiles. This detailed description of the spatiotemporal expression patterns of CD46 provides a valuable tool for analysis of spermatogenesis in the rat. Furthermore, this information will aid ongoing studies regarding the roles of CD46 in acrosome-related spermatozoal functions.
INTRODUCTION
The seminiferous tubuli of the testis play an essential role in the production and maturation of the male germ cells. The complexity of this task is reflected in the intricate organization of the tubuli, comprising a series of stages of epithelial structure. In humans, six distinct stages have been identified, but in the rat, 14 stages can be distinguished based on the tubular composition and structure. Spermatid development into spermatozoa is equally complex, com-prising 19 steps in the rat [1, 2] . When testis sections are examined, different stages of the epithelial cycle will be seen in each section. These usually are differentiated based on multiple microscopic features, including the frequency of meiotic and mitotic figures, spermatid shape, presence and position of elongated spermatids, possession of periodic acid-Schiff (PAS)-positive Golgi apparatus, mitochondrial alignment, acrosome shape, and presence of clusters of elongated spermatids [1, 2] . However, these multiple markers are difficult to evaluate using either light or fluorescence microscopy, provoking a search for more specific markers. A number of markers of the acrosome have been reported in hamsters, humans [3] [4] [5] [6] [7] , mice [8, 9] , and rats [10, 11] . However, the nature of the antigenic marker molecule in most cases, and particularly in the rat, is unclear.
The membrane cofactor protein (MCP), also known as CD46, was first described as a membrane complement regulator that functions as a cofactor with factor I to regulate the activating enzymes of the complement cascade. More recently, human CD46 has been shown to be a multitasking molecule. Among other activities, CD46 is utilized as a receptor for several species of bacteria and viruses [12] [13] [14] [15] [16] , acts as a costimulatory molecule on T cells [17] [18] [19] [20] , and is a ligand for DLG4, a cytoskeletal protein that is involved in cell polarization [21] . In humans, CD46 exists as multiple isomeric forms and is broadly distributed [22, 23] . Human spermatozoa express only an isoform comprising the four short consensus repeat (SCR) domains, the short Ser/Thr/Pro-rich domain C, and the Cyt2 variant of the cytoplasmic tail. The N-linked carbohydrate groups in spermatozoal CD46 also are uniquely trimmed to small, simple structures, explaining the low apparent molecular weight of the protein at this site [24] . Spermatozoal CD46 is identical to the previously described acrosome-restricted spermatozoal protein trophoblast-leukocyte common antigen [25] [26] [27] [28] , and it has been ascribed roles in fertilization [29] [30] [31] . Because of its acrosome-restricted expression pattern, spermatozoal CD46 has been utilized as a specific acrosome marker in humans [32, 33] .
In contrast to the widespread distribution in humans, CD46 in rats, mice, and guinea pigs has been shown by mRNA analysis to be expressed predominantly or exclusively in the testis [34] [35] [36] . Recent studies of the distribution of CD46 protein in mice and rats confirm the testisspecific localization and suggest that CD46 in each of these species is acrosome-restricted [37, 38] . However, the detailed distribution of CD46 in developing spermatozoa in the various stages of the seminiferous tubuli remains unclear in any species. In the present study, we undertook to analyze in detail the presence and distribution of CD46 in the rat testis at each stage of the seminiferous tubuli to further clarify the roles of CD46 in sperm development and function. Analysis of CD46 expression was found to be a clear and reliable aid to the staging of seminiferous tubules, providing a useful complement to traditional markers.
MATERIALS AND METHODS

Antibodies and Markers for Immunohistochemistry
The monoclonal antibody (mAb) against rat CD46, MM.1, recognizing the SCR2 and SCR3 domains of rat CD46, has been previously described [38] . A second, previously undescribed mAb against rat CD46, MM.2, was generated from a mouse immunized with the SCR1, SCR2, and SCR3 domains of rat CD46 expressed as a fusion protein on human immunoglobulin (Ig) Fc essentially as described previously [38] . This new mAb specifically recognized SCR1 of rat CD46. The mAb 18.6, a kind gift from Prof. H. Moore (University of Sheffield, Sheffield, U.K.), was used as an acrosome marker [4] . This mAb, raised against an undefined epitope on hamster spermatozoa, has been shown to react specifically with the acrosome in rats. All of these mAbs were mouse IgG1. Tetramethylrhodamine isothiocyanate (TRITC)-labeled phalloidin was used to detect Factin (Sigma-Aldrich, Dorset, U.K.). 4Ј-6-Diamino-2-phenylindole-2HCl (DAPI; Sigma) was used at a final concentration of 100 ng/ml to stain cell nuclei.
The secondary antibodies used were fluorescein isothiocyanate (FITC)-labeled goat anti-mouse IgG (Bio-Rad, California) and rhodamine-labeled donkey anti-mouse IgG (Jackson ImmunoResearch Laboratories, Philadelphia, PA). The FITC-labeled goat anti-mouse IgG was pretreated with normal rat serum (1:1, v/v) before use. As a further control, we used an in-house isotype-matched IgG1 mAb without any specific binding on rat tissues. The mAb MM.1 was directly FITC-labeled by incubation with Nhydroxysuccinimide-FITC according to the manufacturer's instructions (Pierce, Rockford, IL).
Immunofluorescence and Histological Procedures
Male Wistar rats (age, 12-16 wk) were humanely killed using U.K. Home Office-approved methods, and their testes were removed, cut into blocks, and snap-frozen in isopentane at Ϫ40ЊC. Frozen tissues were sectioned in a cryostat (thickness, 5 m) and fixed in acetone at room temperature for 5 min.
When double-immunostaining was used, the specificity of staining for each reagent was confirmed before double-staining. To compare the localization of rat CD46 with nuclear shape and F-actin distribution, MM.1 was first incubated on the specimens, followed by FITC-labeled goat-anti mouse IgG with DAPI (final concentration, 100 ng/ml) and TRITC-labeled phalloidin (final concentration, 100 ng/ml). To compare rat CD46 localization and mAb 18.6 staining, specimens were first incubated for 60 min at room temperature with mAb 18.6 (neat tissue-culture supernatant), followed by rhodamine-labeled donkey anti-mouse IgG for 30 min. The specimens were then blocked with the isotype control mouse IgG1 for 15 min and incubated with FITC-labeled mAb MM.1 for 60 min. The specimens were finally embedded with VectaShield (Vector Laboratories, CA) and observed under immunofluorescence (IF) microscopy.
For some analyses, selected sequential sections from the above-mentioned IF study were stained with hematoxylin and eosin (hematoxylineosin) to confirm the stage in the seminiferous tubuli according to the protocol described by Hess [1, 2] . As further confirmation of the IF localization, sequential sections also were stained with an avidin-biotin-peroxidase protocol. Briefly, the sections were pretreated with 0.3% H 2 O 2 to block endogenous peroxidase and treated with the avidin-biotin-blocking reagent according to the manufacturer's protocol (Vector Laboratories). The mAb MM.1 was incubated for 30 min on sections, followed by biotinlabeled goat anti-mouse IgG (Sigma). The specimens were processed using the Vectastain Elite ABC kit (Vector Laboratories) according to the manufacturer's instructions. Development was performed using diaminobenzidine tetrahydrochloride (DAB) development reagents (Sigma fast; Sigma). Finally, counterstaining was performed with hematoxylin.
The IF staining pattern for mAb MM.1 in different tubule profiles was characterized with respect to three different aspects. First, intensity of IF staining was graded into five categories: negative (Ϫ), very weak (Ϯ), weak (ϩ), moderate (ϩϩ), and strong (ϩϩϩ). Second, positive cells in each profile were classified into one of seven staining patterns as detailed further in the Results and in Chart 1. Third, whether a single staining pattern (representing one step in spermatid development) or two distinct patterns (representing two different stages of spermatid development) were present in the profile was determined.
To confirm specificity of staining, the mAb MM.1 was preincubated with a twofold molar excess of the rat MCP SCR2 and SCR3 Fc-fusion protein overnight at 4ЊC before testing with immunohistochemistry as described above.
Immunoelectron Microscopic Analysis
To confirm the ultrastructural location of CD46 in rat spermatozoa, we performed immunoelectron microscopic analysis. Harvested testis and epididymis from killed Wistar rats were fixed with periodate-lysine-paraformaldehyde at 4ЊC for 4 h. Fixed specimens were embedded in OCT compound (Sakura Finetechnical Co., Tokyo, Japan) and snap-frozen in liquid nitrogen. The frozen tissues were cut (thickness, 8 m), and sections were air-dried. Sections were washed with 10% sucrose in PBS and pretreated in 0.3% H 2 O 2 in methanol for 20 min, followed by 5% goat serum in PBS for 30 min as a block. The treated sections were incubated with mAb MM.1 (7.5 g/ml in PBS overnight at 4ЊC), followed by horseradish peroxidase-labeled goat anti-mouse IgG (F(abЈ); Histofine Simple Stain MAX-PO(M); Nichirei Corporation, Tokyo, Japan) for 30 min at room temperature. After washing, the sections were fixed in 1% glutaraldehyde for 5 min. The DAB development was performed with the Envision kit/ horseradish peroxidase (Dako Cytomation, Tokyo, Japan). Developed sections were postfixed with 1% OsO 4 for 1 h, dehydrated through sequential ethanol dilutions, and embedded in Epon 812 (Nisshin EM Co., Tokyo, Japan). Sections were viewed on a H7100 electron microscope (Hitachi Co. Ltd., Ibaraki, Japan).
RESULTS
Immunoelectron Microscopy Confirms AcrosomeRestricted Expression of CD46
Using standard immunoelectron microscopic methods, the anti-rat CD46 mAb MM.1 strongly stained the inner membranes of the acrosome in rat epididymis spermatozoa (Fig. 1A) . The CD46 staining was clearly visible inside the acrosome and extended to the tip of the spermatozoon (Fig.  1B) . The tail portions of all cells were completely negative (Fig. 1, C and D) . During spermatogenetic development, CD46 staining was first detected in step 7 spermatids (the earliest step at which CD46 expression was apparent; see below) and found both inside and around the Golgi apparatus as well as in the acrosome precursor (Fig. 1E ). In step 8 spermatids, CD46 staining was found inside and around the forming acrosome and inside the Golgi apparatus. At this step, cytoplasmic elongation is apparent, and the Golgi apparatus is migrating to the other side of the nucleus, well separated from the acrosome (Fig. 1F) . The CD46 staining was not detected in the outer cell membrane of spermatids at any step.
Seminiferous Epithelium Staging by DAPI Nuclear Staining and CD46 Staining
Testis sections were double-stained for DAPI and CD46 as described in Materials and Methods. Each pair of plates in Figure 2 comprised the same section, stained for DAPI and CD46 (using mAb MM.1), respectively. The DAPI staining of seminiferous epithelium clearly defined the round nuclei of spermatids at steps 1-9 (Fig. 2, A, C , E, G, I, and K). The CD46 staining was negative on round spermatids in steps 1-6 and was first detected in step 7 spermatids, in which staining was weak and diffuse ( Fig.  2H and Chart 1). In step 8 and 9 spermatids, CD46 expression was weak and clearly displaced to one side of the cell (Fig. 2, J and L, and Chart 1). The DAPI staining was observed in characteristic patterns in the elongated nuclei of spermatids at steps 10-19. Intensity of DAPI staining increased through steps 11-13 of spermatid development (Fig. 2 , O and Q) and was strongest through steps 14 and 15 (Fig. 2, A and S) , likely reflecting nuclear condensation during these steps. After step 16 of rat spermatid development, the intensity of DAPI staining was decreased, suggesting that nuclear condensation was diminished (Fig. 2,  G and I) . The CD46 was weakly expressed in an elongated distribution to the caudal side in step 10 spermatids (Fig.   2N ). Staining was stronger and extended across the tip of the nucleus and to both nuclear edges in spermatids from step 11 to step 14 ( Fig. 2 , P, R, and T) and was concentrated in the caudal and dorsal sides in spermatids of steps 15 and 16 (Fig. 2, B and D) . Staining for CD46 was strong and deviated to the dorsal side of the nucleus, including the tip, in step 17 spermatids (Fig. 2F) . In spermatids of steps 18 and 19, staining was strong and clearly sickle-shaped in a typical acrosome distribution (Fig. 2, H and J) , resembling the acrosome staining of swim-up spermatozoa as previously reported [38] .
Chart 1 summarizes the epithelial staging obtained from CD46 and DAPI staining. Other aids for staging of the seminiferous epithelium were provided by the prominent bundling of elongated spermatids from step 10 through step 18 evident from DAPI and CD46 staining (clearly shown in Fig. 2 , A-F and M-T), the position of isolated cells and bundles in the walls of the seminiferous tubules, and the presence, in some profiles, of more than one step in spermatid development (Chart 1). With increasing maturity, CD46-stained spermatids were located progressively closer to the lumen of the tubule. Spermatids of step 7 through step 9 were located near the basement membrane and were not bundled (epithelial stages VII-IX), whereas step 10 spermatids were loosely bundled in this same area (stage X). Spermatids of step 11 through step 14 were tightly bundled and predominantly situated in the middle layer of seminiferous tubule profiles (defining seminiferous epithelial stages XI-XIV). Spermatids of step 15 through step 17 were present in bundles in the middle layer (stages I-IV) and also close to Sertoli cells along the basement membrane (stage V). Spermatids of step 18 and step 19 were bundled and predominantly sublumenal (stage VI) or unbundled and lining the lumen (stages VII and VIII) of seminiferous tubuli. Spermatids placed in steps 18 and 19 based on CD46 staining were present by themselves in stage VI profiles 911 CD46 DISTRIBUTION DURING SPERMATOZOAL DEVELOPMENT CHART 1. CD46, DAPI, 18.6, and F-actin staining at different stages of the seminiferous epithelium cycle. The presence of bundle formation (#) of elongated spermatids is shown as Ϫ, negative or ϩ, positive. The degree of phalloidin binding (*) to F-actin and mAb 18.6 binding are shown as Ϫ, negative; ϩ/Ϫ, trace; ϩ, weak; and ϩϩ, strong.
(defined as step 18), with step 7 spermatids in stage VII (defining as stage 19) (Fig. 2H) , and with step 8 spermatids in stage VIII (Fig. 2J) .
Comparison of Seminiferous Epithelium Staging by Hematoxylin-Eosin Staining and CD46 Staining
Seminiferous epithelial staging is classically performed by staining sections with hematoxylin-eosin and/or PAS. In serial frozen sections of testis, we compared hematoxylineosin staining with staining for CD46, with the latter detected either using IF (as in Fig. 2 ) or a peroxidase method for easier comparison of tissue architecture. Hematoxylineosin staining identified ongoing mitosis in spermatogonia, meiosis in spermatocytes, and spermiogenesis in elongated spermatids, with the latter easily identified morphologically in sections (Fig. 3, A1-I1 ). Staining for CD46 and detection using a peroxidase method gave results essentially identical to those obtained from IF (Fig. 3 , compare A2-I2 with sequential sections in A3-I3). Although in many hematoxylin-eosin-stained profiles approximate epithelial staging was possible from morphological analyses and position of stained cells as detailed in the preceding section, CD46 staining provided a clearer distinction between stages as described in Figure 2 and Chart 1.
Confirmation of Specificity of CD46 Staining
The mAb MM.1 has been characterized previously as anti-CD46 [38] . To confirm further the specificity of staining with this mAb, we first compared the staining pattern of a novel anti-CD46 mAb, MM.2, generated against a different region of rat CD46 (SCR1). No staining with this mAb was found in a large panel of rat tissues with the sole exception of testis (not shown). The mAb MM.2 gave a staining pattern identical to that of MM.1 in testis sections (Fig. 4, A and B, respectively) . As a further test of specificity, we adsorbed the mAb MM.1 with the CD46 SCR2 and SCR3 fusion protein used to generate the mAb. Adsorbed mAb lost all reactivity with testis sections, whereas an irrelevant fusion protein was without effect, confirming the specificity of the mAb (Fig. 4, C and D) . Neither MM.1 nor MM.2 stained human spermatozoa or mouse testis in the IF study and Western blot analyses (data not shown).
Comparison Between Staining for the Acrosome Marker 18.6 and CD46 in Rat Spermatids
Staining with mAb 18.6 has been used as an aid to identifying the acrosome and staging seminiferous epithelium in several species. In the present study, we compared expression in rat testis of CD46 and 18.6 antigen by doublestaining. As described above, CD46 expression was first present at step 7 and steadily increased in intensity through spermatid development. Staining with mAb 18.6 was first present at step 9 (Fig. 5A) . Staining was weak and patchy through steps 9 and 10 and was much more restricted in distribution compared with CD46 at these stages (Fig. 5, A  and B) . From step 11 onward, mAb 18.6 staining was stronger and became increasingly coincident with CD46 staining 
FIG. 4.
Confirmation of specificity of staining for CD46. Serial testis sections were stained with mAb MM.1 raised against SCR1, SCR2, and SCR3 domains of rat CD46 (A) or mAb MM.2 raised against the SCR1 domain of rat CD46 (B). The staining patterns with these two noncompetitive mAb are identical, confirming that the are staining CD46 in testis. The MM.1 mAb was adsorbed with the SCR2 ϩ 3 fusion protein used as immunogen and then applied to testis sections. Staining was completely abolished by this adsorption step (C), whereas incubation with an irrelevant fusion protein had no effect on staining (D). Original magnification ϫ200. (Fig. 5, C and D) , approaching complete overlap by steps 18 and 19 (Figs. 5, E and F, and 6). In step 19 spermatids and in spermatozoa in the lumen of the cauda epididymis, mAb 18.6 and CD46 staining were coincident (Fig. 6 ).
Comparison Between Staining for F-Actin and CD46 in Rat Spermatids
The F-actin staining has been used previously in the staging of seminiferous tubule profiles in the rat [39, 40] . In our hands, F-actin expression, detected by phalloidin staining, was first present in spermatids at step 7, which is the step that first expresses CD46, and remained weak through steps 7-10 ( Fig. 5, G and H) . Through steps 11-16, the expression of F-actin gradually increased and was strongest at steps 17-19 as previously reported (Fig. 5, I -K) [39, 40] . The association of strong F-actin staining with characteristic CD46 staining patterns in spermatids of steps 17-19 provided independent confirmation of the staging of seminiferous epithelium profiles through stages IV-VII. Stage VIII seminiferous epithelium has been correlated previously with a reduced F-actin staining [39, 40] . In the present study, stage VIII, defined by CD46 staining, with the coexistence of spermatids at step 19 and step 8, was clearly associated with reduced F-actin staining, thus confirming the staging (Fig. 5L) .
DISCUSSION
Accurate staging of spermatogenesis and the seminiferous tubule cycle is necessary for studies of spatiotemporal and D) , and combined images (E and F) are shown. Nuclei were counterstained with DAPI (blue). These images confirm that CD46 expression occupies a broader area compared to 18.6 antigen staining in step 19 spermatids (arrows in A and E), whereas in spermatozoa, the expression patterns are identical for the two antigens. Original magnification ϫ1000; each image is magnified ϫ3 from the original pictures.
aspects of protein and gene expression in germ cell development. Current staging of the seminiferous tubuli is dependent on multiple light microscopic findings on hematoxylin-eosin-and PAS-stained sections and requires the skills of a pathology specialist [1, 2] . Most of the markers used require subjective estimations of staining intensity that can be problematic. In particular, few good markers of the developing acrosome are available in humans and experimental animals. During the last few years, CD46 has emerged as a useful acrosome marker in humans, but to our knowledge, it has not been explored in other species. We recently described generation of an mAb against the rat analogue of the complement regulatory molecule CD46 and showed that its expression is limited to the acrosome region in developing and mature spermatozoa [38] . In the present study, we analyzed in detail the staining pattern and distribution of CD46 in developing spermatids and showed that categorization of the different staining patterns, together with position in the seminiferous epithelium profiles, can be accurately related to the various steps of spermatogenesis. The identity of the antigen has been confirmed using mAb against different regions of CD46 and by specific adsorption of the mAb with CD46 fusion proteins. Expression of CD46, first detected on step 7 intermediate spermatids, became stronger and adopted the deviated distribution that is characteristic of the developing acrosome through steps 8-14 of spermatid development. After step 14, CD46 distribution was concentrated into the position of the mature acrosome. We confirmed that rat CD46 was not expressed in early round spermatids or the earlier spermatogenic cells, including spermatogonium and spermatocytes. We used immunoelectron microscopy to delineate further the expression of CD46 on spermatozoa and developing spermatids. In late spermatids and mature spermatozoa, CD46 was acrosome-restricted, with no staining of the residual Golgi apparatus. In the earliest-expressing spermatids (steps 7 and 8), expression was found in the Golgi apparatus and the early acrosome structure. Before step 7, CD46 was not detected either in the Golgi apparatus or in the forming ac-rosomal vesicle. This sequence of events suggests that CD46 is transferred from the Golgi apparatus to the acrosome during the early stages of acrosome formation. No CD46 expression was detectable on cell membranes at any stage in the development of spermatozoa.
Recognition of the stage of maturation of seminiferous epithelium in tubule profiles is necessary for analyzing the relationship between the different types of spermatogenic cells. Few specific markers are available, and none alone has the power to identify the stage [41] [42] [43] [44] . Staining for CD46 provides an acrosome marker that, when combined with DAPI staining and morphological parameters (bundling and position in profile), enables accurate staging. Inclusion of actin filament staining, which is enhanced in lateelongated spermatids and decreased just before completion of sperm transformation and release to the lumen, further supports the staging of spermatids by CD46 expression patterns during these later steps of development [39, 40] .
Of note, CD46 expression appeared at earlier stages of spermatid development than the known acrosome marker 18.6 antigen [4] . Expression of CD46 was present from step 7, whereas 18.6 antigen was not detected until step 9. Furthermore, although in the later steps of elongated spermatids and in mature spermatozoa the distribution of CD46 coincided with that of 18.6 antigen and faithfully delineated the acrosome, CD46 distribution before step 12 was broader than that of 18.6 antigen. This early expression of CD46, also apparent in immunoelectron microscopy to include Golgi staining, as noted above, suggests specific roles in spermatogenesis or the maturation of the acrosome.
Human CD46 is now recognized as a multitasking molecule with roles outside complement regulation, including as a receptor for several microorganisms [12] [13] [14] [15] [16] and as a costimulatory molecule for T-cell activation [17] [18] [19] [20] . The fascinating expression pattern of rat CD46 revealed in the present study is consistent with roles for CD46 in enhancing sperm-egg interaction, as suggested for human CD46 [7, [29] [30] [31] . However, in a recent report describing CD46 knockout mice [37] , the possibility of a suppressive role for CD46 in fertilization has emerged. The CD46 knockout mice display an accelerated acrosome reaction and enhanced fertility, perhaps suggesting an acrosome-stabilizing role for CD46. In rat, the roles of CD46 remain unclear, but the availability of specific mAb might help with the progress of further analysis concerning the roles of CD46 in the rodent and human reproductive systems. Delineation of the detailed spatiotemporal aspects of CD46 expression in the rat testis will be useful to support these further analyses.
